SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 12.43 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 0.51 |
Book Value / Share | 0.01 |
Price / Book | n/a |
NCAV ($M) | -2.90 |
NCAV / Share | -0.07 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -4.11 |
Return on Assets (ROA) | -0.45 |
Return on Equity (ROE) | -1.78 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.14 |
Current Ratio | 2.29 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.51 |
Assets | 9.93 |
Liabilities | 9.42 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.19 |
Operating Income | -5.86 |
Net Income | -5.82 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -5.68 |
Cash from Investing | -0.10 |
Cash from Financing | 2.98 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
CKDXF – Opthea Limited | CLCS – Cell Source, Inc. |
CLVR – Clever Leaves Holdings Inc. | CMRA – Comera Life Sciences Holdings, Inc. |
CMVLF – Cellectis S.A. |
Financial data and stock pages provided by
Fintel.io